Abeona Therapeutics (ABEO) Director Mark Alvino Sells 15,000 Shares

What Happened
Mark Alvino, a director of Abeona Therapeutics, reported the sale of 15,000 common shares on September 1, 2026. The reported weighted-average price was $5.86 per share, for total proceeds of approximately $87,966. This was a sale (disposition) — not a purchase or award — and therefore does not directly signal insider buying interest.

Key Details

• Transaction date: 2026-09-01. Transaction type: S (open market or private sale).
• Price: weighted average $5.86; per-footnote sold in multiple trades at prices ranging $5.80 to $5.9250.
• Total proceeds: ~$87,966.
• Shares owned after the transaction: not disclosed in the provided filing.
• Footnote: the filing states the $5.86 is a weighted-average price and the reporting person will provide, upon request, the number of shares sold at each separate price within the stated range.
• Filing timeliness: reported with the filing dated 2026-09-01 (no indication of a late filing).

Context
Code S sales are often routine (open-market or private dispositions) and do not by themselves indicate the insider’s view of the company. There is no indication in this filing of a 10b5-1 plan, option exercise, gift, or tax-withholding event tied to these shares. If you want a per-trade price breakdown, the reporting person has offered to provide that detail on request.